|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Cash, securities and other assets segregated under federal and other regulations (including $888.5 million and $950.0 million at fair value at June 30, 2026 and September 30, 2025, respectively) | ||||||||||||||||||||
| Collateralized transactions: | ||||||||||||||||||||
| Securities purchased under agreements to resell | ||||||||||||||||||||
| Securities borrowed | ||||||||||||||||||||
| Deposits with and receivables from broker-dealers, clearing organizations and counterparties, net (including $5,414.0 million and $6,442.9 million at fair value at June 30, 2026 and September 30, 2025, respectively) | ||||||||||||||||||||
| Receivable from clients, net (including $70.3 million and $58.1 million at fair value at June 30, 2026 and September 30, 2025, respectively) | ||||||||||||||||||||
| Notes receivable, net | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Financial instruments owned, at fair value (includes securities pledged as collateral that can be sold or repledged of $2,244.1 million and $1,165.8 million at June 30, 2026 and September 30, 2025, respectively) | ||||||||||||||||||||
| Physical commodities inventory, net (including $413.5 million and $471.1 million at fair value at June 30, 2026 and September 30, 2025, respectively) | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating right of use assets | ||||||||||||||||||||
| Goodwill and intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Accounts payable and other accrued liabilities (including $57.5 million and $32.3 million at fair value at June 30, 2026 and September 30, 2025, respectively) | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Payables to: | ||||||||||||||||||||
| Clients (including $1,033.2 million and $530.7 million at fair value at June 30, 2026 and September 30, 2025, respectively) | ||||||||||||||||||||
| Broker-dealers, clearing organizations and counterparties (including $27.0 million and $38.4 million at fair value at June 30, 2026 and September 30, 2025, respectively) | ||||||||||||||||||||
| Lenders under loans | ||||||||||||||||||||
| Senior secured borrowings, net | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Collateralized transactions: | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Securities loaned | ||||||||||||||||||||
| Financial instruments sold, not yet purchased, at fair value | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value. Authorized 1,000,000 shares; no shares issued or outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value. Authorized 200,000,000 shares; 126,225,774 issued and 119,995,698 outstanding at June 30, 2026 and 123,649,546 issued and 117,419,470 outstanding at September 30, 2025 | ||||||||||||||||||||
| Common stock in treasury, at cost. 6,230,076 shares at June 30, 2026 and September 30, 2025 | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
